Transcatheter Mitral Valve Repair with MitraClip™

• MitraClip™ is an FDA-approved cardiac device designed to treat severe Mitral Valve Regurgitation without doing open-heart surgery. The interventional cardiologist inserts a narrow tube called a catheter into a large vein in the upper leg and guides it into the left side of the heart to the mitral valve.
• There the MitraClip device is attached to the leaflets of the leaky mitral valve, helping it to close more effectively and immediately improving heart function. The MitraClip is a permanent implanted device.
• This procedure is performed under general anesthesia in the cardiac catheterization lab. It typically takes about two hours.
• Most patients go home in one or two days. Patients can start taking short easy walks the next day and gradually increase activities during the one to two week recovery period.
• People who have severe Mitral Valve Regurgitation can discuss the MitraClip procedure with their cardiologist. A specialized echocardiogram done at the medical center is required along with other tests to determine if a patient qualifies for MitraClip.

Meet our MitraClip team

PATRIK C. ZETTERLUND, MD
Interventional Cardiology

RIKIN KADAKIA, MD
Interventional Cardiology

VINCENT J. DEFILIPPI, MD
Cardiac Surgery

KANAE MUKAI, MD
Cardiology

ANDREAS G. SAKOPOULOS, MD
Cardiac Surgery

AJANTA DE, MD
Interventional Cardiology

ANNE TIMBERLAKE, RN, MSN
MitraClip Program Coordinator